1. Home
  2. MIST vs FLYX Comparison

MIST vs FLYX Comparison

Compare MIST & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.36

Market Cap

163.2M

Sector

Health Care

ML Signal

HOLD

Logo flyExclusive Inc.

FLYX

flyExclusive Inc.

N/A

Current Price

$4.00

Market Cap

79.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MIST
FLYX
Founded
2003
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
163.2M
79.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MIST
FLYX
Price
$2.36
$4.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.33
N/A
AVG Volume (30 Days)
5.3M
15.2K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$362,955,000.00
Revenue This Year
N/A
$28.47
Revenue Next Year
N/A
$22.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.38
52 Week Low
$0.63
$1.90
52 Week High
$3.06
$6.90

Technical Indicators

Market Signals
Indicator
MIST
FLYX
Relative Strength Index (RSI) 46.58 59.08
Support Level $2.50 $3.48
Resistance Level $2.73 $4.22
Average True Range (ATR) 0.26 0.41
MACD -0.02 0.10
Stochastic Oscillator 48.62 79.66

Price Performance

Historical Comparison
MIST
FLYX

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: